Policymakers

Precision cardiology is becoming the new oncology. Policy and reimbursement must catch up

Chronic pain may be a cardiovascular warning sign, not just a symptom

Diarrhoeal Disease Progress Is Real. The Inequality Is Still Brutal.

Could AI help prevent the next athlete cardiac tragedy? Evidence is moving faster than practice

WHO is preparing to ration the obesity drug revolution before it becomes another access disaster

Europe’s AMR Strategy Depends on the Lab Result Being Right

Heatwaves are emerging as a cardiovascular risk factor, prompting calls for stronger climate adaptation and public health policies

Eli Lilly’s retatrutide could reset obesity care, but rising demand and grey-market access are testing regulators and health systems

Metabolic health is no longer just a clinic problem. It is a city, climate and equity problem
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
